Edelman’s ‘100-year life’ report suggests
Author: Michael
The global oligonucleotide therapeutics market is
Harness Therapeutics has nominated HRN001 as a fi
Wellbeing International Foundation backs cell-fr
Sana’s early diabetes data suggest hypoimmune
Belgium’s long-time biotech backer is stepping
Weight-loss pills are reshaping the market, but
QuantalX Neuroscience leverages FDA De Novo clea
PD-AGE roadmap calls for older, standardized pre
Vesalic targets ‘toxic exosome’ identified i